Neubauer A - Search Results

1

Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib.

Hanfstein B, Lauseker M, Hehlmann R, Saussele S, Erben P, Dietz C, Fabarius A, Proetel U, Schnittger S, Haferlach C, Krause SW, Schubert J, Einsele H, Hänel M, Dengler J, Falge C, Kanz L, Neubauer A, Kneba M, Stegelmann F, Pfreundschuh M, Waller CF, Spiekermann K, Baerlocher GM, Pfirrmann M, Hasford J, Hofmann WK, Hochhaus A, Müller MC; SAKK and the German CML Study Group. Hanfstein B, et al. Among authors: neubauer a. Haematologica. 2014 Sep;99(9):1441-7. doi: 10.3324/haematol.2013.096537. Epub 2014 May 16. Haematologica. 2014. PMID: 24837466 Free PMC article. Clinical Trial.

2

Quantification of Bcr-Abl transcripts in chronic myelogenous leukemia (CML) using standardized, internally controlled, competitive differential PCR (CD-PCR).

Nagel S, Schmidt M, Thiede C, Huhn D, Neubauer A. Nagel S, et al. Among authors: neubauer a. Nucleic Acids Res. 1996 Oct 15;24(20):4102-3. doi: 10.1093/nar/24.20.4102. Nucleic Acids Res. 1996. PMID: 8918822 Free PMC article.

3

Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CML.

Fischer T, Neubauer A, Mohm J, Huhn D, Busemann C, Link H, Arseniev L, Büssing B, Novotny J, Ganser A, Duyster J, Bunjes D, Kreiter S, Aulitzky W, Hehlmann R, Huber C. Fischer T, et al. Among authors: neubauer a. Bone Marrow Transplant. 1998 May;21(10):1029-36. doi: 10.1038/sj.bmt.1701229. Bone Marrow Transplant. 1998. PMID: 9632277

4

Kinetics of the graft-versus-leukemia response after donor leukocyte infusions for relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation.

Baurmann H, Nagel S, Binder T, Neubauer A, Siegert W, Huhn D. Baurmann H, et al. Among authors: neubauer a. Blood. 1998 Nov 15;92(10):3582-90. Blood. 1998. PMID: 9808551 Free article.

5

Potential of autologous immunologic effector cells for prediction of progression of disease in patients with chronic myelogenous leukemia.

Müller M, Scheffold C, Lefterova P, Huhn D, Neubauer A, Schmidt-Wolf IG. Müller M, et al. Among authors: neubauer a. Leuk Lymphoma. 1998 Oct;31(3-4):335-41. doi: 10.3109/10428199809059226. Leuk Lymphoma. 1998. PMID: 9869197

6

Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapy.

Schmidt M, Hochhaus A, König-Merediz SA, Brendel C, Proba J, Hoppe GJ, Wittig B, Ehninger G, Hehlmann R, Neubauer A. Schmidt M, et al. Among authors: neubauer a. J Clin Oncol. 2000 Oct 1;18(19):3331-8. doi: 10.1200/JCO.2000.18.19.3331. J Clin Oncol. 2000. PMID: 11013272

7

Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-alpha.

Schmidt M, Hochhaus A, Nitsche A, Hehlmann R, Neubauer A. Schmidt M, et al. Among authors: neubauer a. Blood. 2001 Jun 1;97(11):3648-50. doi: 10.1182/blood.v97.11.3648. Blood. 2001. PMID: 11369663 Free article.

8

Intensified double induction therapy with high dose mitoxantrone, etoposide, m-amsacrine and high dose ara-C for elderly acute myeloid leukemia patients aged 61-65 years.

Schaich M, Illmer T, Aulitzky W, Bodenstein H, Clemens M, Neubauer A, Repp R, Schäkel U, Soucek S, Wandt H, Ehninger G; SHG AML96 Study Group. Schaich M, et al. Among authors: neubauer a. Haematologica. 2002 Aug;87(8):808-15. Haematologica. 2002. PMID: 12161356 Clinical Trial.

9

Interferon-alpha, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia.

Burchert A, Wölfl S, Schmidt M, Brendel C, Denecke B, Cai D, Odyvanova L, Lahaye T, Müller MC, Berg T, Gschaidmeier H, Wittig B, Hehlmann R, Hochhaus A, Neubauer A. Burchert A, et al. Among authors: neubauer a. Blood. 2003 Jan 1;101(1):259-64. doi: 10.1182/blood-2002-02-0659. Epub 2002 Jun 28. Blood. 2003. PMID: 12393722 Free article.

10

Normal intrinsic Th1/Th2 balance in patients with chronic phase chronic myeloid leukemia not treated with interferon-alpha or imatinib.

Kiani A, Habermann I, Schäke K, Neubauer A, Rogge L, Ehninger G. Kiani A, et al. Among authors: neubauer a. Haematologica. 2003 Jul;88(7):754-61. Haematologica. 2003. PMID: 12857553

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

870 results

Search Page

Filters